NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/Cirrhosis
    Cirrhosis
    medium
    microscope Pathology

    A 52-year-old man with biopsy-proven cirrhosis (Child-Pugh Class B) presents with haematemesis and melaena. On endoscopy, active bleeding from oesophageal varices is confirmed. After initial resuscitation and blood product transfusion, bleeding is controlled with endoscopic variceal ligation (EVL). What is the most appropriate next step in management?

    A. Perform transjugular intrahepatic portosystemic shunt (TIPS) immediately
    B. Repeat endoscopy in 2 weeks for surveillance
    C. Discharge with advice to avoid alcohol and arrange outpatient follow-up in 1 month
    D. Start propranolol (target heart rate reduction of 25%) and schedule repeat EVL in 2–4 weeks

    Explanation

    ## Management of Acute Variceal Bleeding in Cirrhosis ### Immediate Post-EVL Strategy **Key Point:** After successful EVL for acute variceal bleeding, the next step is to initiate beta-blocker therapy AND schedule repeat EVL sessions to achieve variceal eradication. **High-Yield:** EVL is a mechanical intervention that controls acute bleeding but does not prevent recurrence. Repeat sessions (typically 2–4 weeks apart) are required until variceal eradication is achieved (defined as absence of varices on endoscopy). ### Rationale for Beta-Blocker Therapy 1. **Portal pressure reduction:** Propranolol (and other non-selective beta-blockers) reduce portal venous pressure by decreasing cardiac output and splanchnic vasodilation. 2. **Prevention of rebleeding:** Beta-blockers reduce the risk of rebleeding by ~40% and improve survival. 3. **Target:** Heart rate reduction of 20–25% or absolute reduction to 55–60 bpm indicates adequate beta-blockade. ### EVL Eradication Protocol | Aspect | Details | | --- | --- | | **Timing of repeat EVL** | 2–4 weeks after initial session | | **Goal** | Complete variceal eradication (no visible varices) | | **Sessions required** | Usually 2–4 sessions | | **Follow-up after eradication** | Surveillance endoscopy at 3 months, then 6-monthly | **Clinical Pearl:** The combination of EVL + beta-blocker therapy is superior to either modality alone in preventing rebleeding and improving survival in cirrhotic patients with oesophageal varices. ### Why Other Options Are Incorrect - **Repeat endoscopy in 2 weeks alone:** Surveillance without beta-blocker therapy leaves the patient at high risk of rebleeding. - **Discharge without beta-blocker:** Premature discharge without pharmacological support increases mortality. - **Immediate TIPS:** TIPS is reserved for EVL failure (rebleeding despite 2 EVL sessions) or for patients with gastric varices or portal vein thrombosis. It is not first-line after successful EVL. [cite:Harrison 21e Ch 297]

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions